Tricklebank, M.

Removing Obstacles in Neuroscience Drug Discovery: The Future Path for Animal Models

Markou, A., Chiamulera, C., Geyer, M. A., Tricklebank, M., & Steckler, T. (2009) · Neuropsychopharmacology

Animal testing and alternativesNeuroscience and Neuropharmacology Research

Cited by 328

Innovative solutions to novel drug development in mental health

Insel, T. R., Voon, V., Nye, J. S., Brown, V. J., Altevogt, B. M., Bullmore, E. T., Goodwin, G. M., Howard, R. J., Kupfer, D. J., Malloch, G., et al. (2013) · Neuroscience & Biobehavioral Reviews

Treatment of Major DepressionSchizophrenia research and treatment

Cited by 124

Differential effects of NMDA antagonists on high frequency and gamma EEG oscillations in a neurodevelopmental model of schizophrenia

Phillips, K. G., Cotel, M. C., McCarthy, A. P., Edgar, D. M., Tricklebank, M., O’Neill, M. J., Jones, M. W., & Wafford, K. A. (2012) · Neuropharmacology

Schizophrenia research and treatmentNeuroscience and Neuropharmacology Research

Cited by 100

The role of 5-HT2C receptors in touchscreen visual reversal learning in the rat: a cross-site study

Alsiö, J., Nilsson, S. R. O., Gastambide, F., Wang, R. A. H., Dam, S. A., Mar, A. C., Tricklebank, M., & Robbins, T. W. (2015) · Psychopharmacology

Neurotransmitter Receptor Influence on BehaviorNeural and Behavioral Psychology Studies

Cited by 53